Home›Stock Screener›Syngene International›Quarterly Results

Syngene International Quarterly Results

Latest Quarter Net Profit
₹32 Cr
QSept 2026
Quarterly Results

Syngene International quarterly results. In Sept 2026, Syngene International (SYNGENE) reported revenue ₹861 Cr and net profit ₹32 Cr — revenue -7.0% YoY. Also explore SYNGENE share price history to track price trends across different timeframes.

SYNGENE Quarterly Results — Revenue, Profit & EPS Highlights

Syngene International latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. View SYNGENE 52-week performance for the annual high/low range and current price position.

  • Revenue of ₹861 Cr in Sept 2026 (-18.7% vs Mar 2026, -7.0% vs Sept 2025)
  • Net Profit of ₹32 Cr in Sept 2026 (-78.4% vs Mar 2026, -52.2% vs Sept 2025)
  • EBITDA of ₹169 Cr in Sept 2026 (-47.2% vs Mar 2026)
  • Operating Margin of 17.0% in Sept 2026 (-12.0pp vs Mar 2026)
  • Earnings Per Share of ₹0.80 in Sept 2026 (-78.3% vs Mar 2026)

Syngene International Quarterly Results — Revenue, EBITDA, Net Profit & EPS

SYNGENE quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric Sept 2026 Mar 2026 Jun 2026 Sept 2025 Mar 2025 QoQ YoY
Revenue (₹ Cr) 861 1,059 761 926 1,037 -18.7% -7.0%
Net Profit (₹ Cr) 32 148 -9 67 183 - -
EBITDA (₹ Cr) 169 320 103 215 363 - -
EPS (₹) 0.80 3.68 -0.22 1.67 4.56 - -
Operating Margin (%) 17.0% 29.0% 11.0% 22.0% 34.0% - -

SYNGENE Share Price Trend — 1-Year Movement Across Quarterly Results

Syngene International 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. For annual financials, live price and key ratios, visit Syngene International share price chart.

Profitability Ratios

Profit Margin 3.7%
EBITDA Margin 19.6%
Operating Margin 17.0%
ROE (Annual) 2.6%

Balance Sheet Highlights

Total Assets ₹7,055 Cr
Total Equity ₹4,839 Cr
Current Assets ₹ Cr
Current Liabilities ₹663 Cr

Cash Flow Analysis

Operating Cash Flow ₹915 Cr
Investing Cash Flow ₹-839 Cr
Financing Cash Flow ₹-215 Cr
Net Cash Flow ₹-139 Cr

Current Market Data

Current Price ₹437.35
Exchange NSE
Last Updated Nov 19, 2026

SYNGENE vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap

Syngene International latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2026
₹451,074.97 Cr 1900.0 16,617 1,995 +10.6% - 12.0% 228.9
Divis Laboratories
Sept 2026
₹294,139.19 Cr 11178.0 3,770 1,127 +26.3% - 29.9% 263.1
Torrent Pharmaceuti…
Mar 2026
₹188,719.51 Cr 4611.0 4,111 364 +27.7% +42.2% 8.9% 400.6
Apollo Hospitals
Sept 2026
₹126,832.45 Cr 8738.0 7,673 660 +15.2% - 8.6% 199.4
Laurus Labs
Sept 2026
₹125,946.78 Cr 2306.0 2,219 436 +21.7% - 19.6% 282.3
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data

QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores